Cencora, Inc.

NYSE

Market Cap.

57.91B

Avg. Volume

1.29M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Cencora, Inc.

Cencora, Inc. News

Cencora, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareMedical - Distribution
amerisourcebergen.com

About Cencora, Inc.

Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Cencora, Inc. Earnings & Revenue

What’s This Company Really Worth? Find Out Instantly.

Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.

Cencora, Inc. Financials

Table Compare

Compare COR metrics with:

   

Earnings & Growth

COR

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

COR

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

COR

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

COR

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Cencora, Inc. Income

Cencora, Inc. Balance Sheet

Cencora, Inc. Cash Flow

Cencora, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityStrong Buy
Return on AssetsBuy
Debt/Equity RatioStrong Sell
Price/Earnings RatioStrong Sell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Cencora, Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

2.2000

Payment DateDividendFrequency
2025-09-030.55Quarterly
2025-06-020.55Quarterly
2025-03-030.55Quarterly
2024-11-290.55Quarterly
2024-08-260.51Quarterly

Historical Market Cap

Shares Outstanding

Cencora, Inc. Executives

NameRole
Mr. Steven H. CollisExecutive Chairman
Dr. Robert P. Mauch Ph.D., PharmDPresident, Chief Executive Officer & Director
Mr. James F. Cleary Jr.Executive Vice President & Chief Financial Officer
Ms. Elizabeth S. Campbell J.D.Executive Vice President & Chief Legal Officer
Ms. Silvana BattagliaExecutive Vice President & Chief Human Resources Officer
NameRoleGenderDate of BirthPay
Mr. Steven H. CollisExecutive ChairmanMale19615.98M
Dr. Robert P. Mauch Ph.D., PharmDPresident, Chief Executive Officer & Director19673.25M
Mr. James F. Cleary Jr.Executive Vice President & Chief Financial OfficerMale19632.4M
Ms. Elizabeth S. Campbell J.D.Executive Vice President & Chief Legal OfficerFemale19751.97M
Ms. Silvana BattagliaExecutive Vice President & Chief Human Resources OfficerFemale19681.72M

Cencora, Inc. Insider Trades

Date19 Aug
NameCOLLIS STEVEN H
RoleExecutive Chairman
TransactionAcquired
TypeM-Exempt
Shares12579
Date19 Aug
NameCOLLIS STEVEN H
RoleExecutive Chairman
TransactionDisposed
TypeS-Sale
Shares14579
Date19 Aug
NameCOLLIS STEVEN H
RoleExecutive Chairman
TransactionDisposed
TypeM-Exempt
Shares12579
Date18 Aug
NameMauch Robert P.
RolePresident & CEO
TransactionAcquired
TypeM-Exempt
Shares3225
Date18 Aug
NameMauch Robert P.
RolePresident & CEO
TransactionDisposed
TypeS-Sale
Shares4968
DateNameRoleTransactionTypeShares
19 AugCOLLIS STEVEN HExecutive ChairmanAcquiredM-Exempt12579
19 AugCOLLIS STEVEN HExecutive ChairmanDisposedS-Sale14579
19 AugCOLLIS STEVEN HExecutive ChairmanDisposedM-Exempt12579
18 AugMauch Robert P.President & CEOAcquiredM-Exempt3225
18 AugMauch Robert P.President & CEODisposedS-Sale4968

Discover More

Streamlined Academy

Cencora, Inc.

NYSE

Market Cap.

57.91B

Avg. Volume

1.29M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Cencora, Inc. News

Cencora, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Cencora, Inc. Earnings & Revenue

Cencora, Inc. Income

Cencora, Inc. Balance Sheet

Cencora, Inc. Cash Flow

Cencora, Inc. Financials Over Time

Cencora, Inc. Executives

NameRole
Mr. Steven H. CollisExecutive Chairman
Dr. Robert P. Mauch Ph.D., PharmDPresident, Chief Executive Officer & Director
Mr. James F. Cleary Jr.Executive Vice President & Chief Financial Officer
Ms. Elizabeth S. Campbell J.D.Executive Vice President & Chief Legal Officer
Ms. Silvana BattagliaExecutive Vice President & Chief Human Resources Officer
NameRoleGenderDate of BirthPay
Mr. Steven H. CollisExecutive ChairmanMale19615.98M
Dr. Robert P. Mauch Ph.D., PharmDPresident, Chief Executive Officer & Director19673.25M
Mr. James F. Cleary Jr.Executive Vice President & Chief Financial OfficerMale19632.4M
Ms. Elizabeth S. Campbell J.D.Executive Vice President & Chief Legal OfficerFemale19751.97M
Ms. Silvana BattagliaExecutive Vice President & Chief Human Resources OfficerFemale19681.72M

Cencora, Inc. Insider Trades

Date19 Aug
NameCOLLIS STEVEN H
RoleExecutive Chairman
TransactionAcquired
TypeM-Exempt
Shares12579
Date19 Aug
NameCOLLIS STEVEN H
RoleExecutive Chairman
TransactionDisposed
TypeS-Sale
Shares14579
Date19 Aug
NameCOLLIS STEVEN H
RoleExecutive Chairman
TransactionDisposed
TypeM-Exempt
Shares12579
Date18 Aug
NameMauch Robert P.
RolePresident & CEO
TransactionAcquired
TypeM-Exempt
Shares3225
Date18 Aug
NameMauch Robert P.
RolePresident & CEO
TransactionDisposed
TypeS-Sale
Shares4968
DateNameRoleTransactionTypeShares
19 AugCOLLIS STEVEN HExecutive ChairmanAcquiredM-Exempt12579
19 AugCOLLIS STEVEN HExecutive ChairmanDisposedS-Sale14579
19 AugCOLLIS STEVEN HExecutive ChairmanDisposedM-Exempt12579
18 AugMauch Robert P.President & CEOAcquiredM-Exempt3225
18 AugMauch Robert P.President & CEODisposedS-Sale4968

Streamlined Academy

Website screenshot
HealthcareMedical - Distribution
amerisourcebergen.com

About Cencora, Inc.

Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Cencora, Inc.

What’s This Company Really Worth? Find Out Instantly.

Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.

Cencora, Inc. Financials

Table Compare

Compare COR metrics with:

   

Earnings & Growth

COR

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

COR

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

COR

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

COR

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Cencora, Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

2.2000

Payment DateDividendFrequency
2025-09-030.55Quarterly
2025-06-020.55Quarterly
2025-03-030.55Quarterly
2024-11-290.55Quarterly
2024-08-260.51Quarterly

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityStrong Buy
Return on AssetsBuy
Debt/Equity RatioStrong Sell
Price/Earnings RatioStrong Sell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

The Secret to Analyzing Winning Stocks (Step-by-Step Examples Inside)